JPS62267250A - 抗不整脈剤 - Google Patents

抗不整脈剤

Info

Publication number
JPS62267250A
JPS62267250A JP62108720A JP10872087A JPS62267250A JP S62267250 A JPS62267250 A JP S62267250A JP 62108720 A JP62108720 A JP 62108720A JP 10872087 A JP10872087 A JP 10872087A JP S62267250 A JPS62267250 A JP S62267250A
Authority
JP
Japan
Prior art keywords
group
formula
compound according
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62108720A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0360814B2 (2
Inventor
ジョン・エドムンド・アロウスミス
ピーター・エドワード・クロス
ジェフリー・ノエル・トーマス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS62267250A publication Critical patent/JPS62267250A/ja
Publication of JPH0360814B2 publication Critical patent/JPH0360814B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP62108720A 1986-05-01 1987-05-01 抗不整脈剤 Granted JPS62267250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868610668A GB8610668D0 (en) 1986-05-01 1986-05-01 Anti-arrhythmia agents
GB8610668 1986-05-01
GB8630059 1986-12-17

Publications (2)

Publication Number Publication Date
JPS62267250A true JPS62267250A (ja) 1987-11-19
JPH0360814B2 JPH0360814B2 (2) 1991-09-17

Family

ID=10597176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62108720A Granted JPS62267250A (ja) 1986-05-01 1987-05-01 抗不整脈剤

Country Status (8)

Country Link
JP (1) JPS62267250A (2)
DD (1) DD268937A5 (2)
GB (1) GB8610668D0 (2)
LV (1) LV5466A3 (2)
MX (1) MX6311A (2)
SU (1) SU1591805A3 (2)
UA (1) UA6154A1 (2)
ZA (1) ZA873078B (2)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3904599B2 (ja) * 1994-08-04 2007-04-11 シー・アンド・シー・リサーチ・ラブズ 新規なアミン誘導体、その製造方法及び抗不整脈剤としての用途
JP2007521269A (ja) * 2003-06-17 2007-08-02 アリーナ ファーマシューティカルズ， インコーポレイテッド ３−ベンズアゼピンを調製する方法
JP2010532382A (ja) * 2007-06-29 2010-10-07 エモリー・ユニバーシテイ 神経保護のためのｎｍｄａ受容体拮抗薬
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3904599B2 (ja) * 1994-08-04 2007-04-11 シー・アンド・シー・リサーチ・ラブズ 新規なアミン誘導体、その製造方法及び抗不整脈剤としての用途
JP2007521269A (ja) * 2003-06-17 2007-08-02 アリーナ ファーマシューティカルズ， インコーポレイテッド ３−ベンズアゼピンを調製する方法
US9102627B2 (en) 2003-06-17 2015-08-11 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
JP4920409B2 (ja) * 2003-06-17 2012-04-18 アリーナ ファーマシューティカルズ， インコーポレイテッド ３−ベンズアゼピンを調製する方法
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8946207B2 (en) 2003-06-17 2015-02-03 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8546378B2 (en) 2004-12-23 2013-10-01 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8802845B2 (en) 2006-04-03 2014-08-12 Arena Phamaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8501935B2 (en) 2006-04-03 2013-08-06 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
JP2010532382A (ja) * 2007-06-29 2010-10-07 エモリー・ユニバーシテイ 神経保護のためのｎｍｄａ受容体拮抗薬
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US9770455B2 (en) 2010-09-01 2017-09-26 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US10463676B2 (en) 2010-09-01 2019-11-05 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
DD268937A5 (de) 1989-06-14
UA6154A1 (uk) 1994-12-29
LV5466A3 (lv) 1994-03-10
MX6311A (es) 1993-08-01
GB8610668D0 (en) 1986-06-04
JPH0360814B2 (2) 1991-09-17
ZA873078B (en) 1988-12-28
SU1591805A3 (ru) 1990-09-07

Similar Documents

Publication Publication Date Title
KR930001339B1 (ko) 부정맥 치료제의 제조방법
EP0178874B1 (en) Alkylsulfonamidophenylalkylamines
US4234595A (en) 3-Indolyl-tertiary butylaminopropanols
CA1086735A (en) Piperidino-quinazolines
JP4571863B2 (ja) 抗痛覚過敏剤として有用なキナゾリノン誘導体
EP0286278B1 (en) Indanamine derivatives useful as antiarrhythmic agents
JPS62267250A (ja) 抗不整脈剤
JPH0567150B2 (2)
PL172933B1 (pl) Sposób wytwarzania nowych pochodnych 3(2H)-pirydazononu PL
JPH0310616B2 (2)
CN102119140B (zh) 1-磷酸鞘氨醇（s1p）受体拮抗剂及其使用方法
US5340811A (en) Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
WO2019170050A1 (zh) 一种2-硫甲基吡唑嘧啶酮类化合物、其制备方法、药物组合物及应用
US4748184A (en) Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility
JPS63255258A (ja) Ｎ−フェネチルアミノアルキル−ベンズアミド抗不整脈剤
JP3904599B2 (ja) 新規なアミン誘導体、その製造方法及び抗不整脈剤としての用途
US4792559A (en) 1,2,3,4-tetrahydroquinoline substituted 5-aminopentanenitrile compounds and their use as calcium modulators
KR960005793B1 (ko) 부정맥 치료제
JPWO1996004231A1 (ja) 新規なアミン誘導体、その製造方法及び抗不整脈剤としての用途
JPS5965087A (ja) 置換１−ピリジルオキシ−３−インドリルアルキルアミノ−２−プロパノ−ルおよびその製法と使用法
US5041462A (en) Novel substituted acetamide compounds and use as anti-allergic agents
KR20010032996A (ko) 신규한 항부정맥 화합물
KR820001449B1 (ko) 퀴나졸린 유도체의 제조방법
US4923873A (en) Quinazoline substituted aminomethyl benzene derivatives
JPH05504778A (ja) 新規３（２ｈ）―ピリダジノン、それを含む医薬組成物及びその調製方法

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070917

Year of fee payment: 16